Core Insights - Harvard Bioscience, Inc. will showcase its latest product innovations at the Society of Toxicology conference from March 17-20, 2025, in Orlando, focusing on enhancing productivity in preclinical research and organoid-based therapeutic development [1][7]. Product Innovations - The SoHo telemetry platform allows researchers to collect and analyze data from multiple small animal models, enhancing the efficiency of neurotoxicity and cardiovascular studies [2][3]. - The VivaMARS™ Activity Monitoring System, powered by Ponemah, offers a GLP-compliant platform for real-time behavioral analysis, catering to the needs of CROs and pharmaceutical companies [4][5]. - The Mesh MEA™ Organoid Platform provides detailed electrophysiological readings from living organoids, supporting research in safety pharmacology and toxicology [6][7]. Market Positioning - The company aims to lower costs and reduce time to market for new biopharma drugs and therapies through its technological advancements [7]. - Harvard Bioscience serves a diverse customer base, including academic institutions, government laboratories, and leading pharmaceutical and biotechnology firms globally [10]. Event Participation - The company will exhibit its solutions at booth 1411 during the Society of Toxicology conference, with representatives available from March 17 to March 19, 2025 [8].
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting